非重症咯血的治疗:保守管理与支气管动脉栓塞的回顾性倾向评分匹配比较
本研究回顾性纳入320例非重症咯血患者(210例保守治疗,110例早期支气管动脉栓塞),经倾向评分匹配后110对基线均衡。匹配队列中两组咯血无复发生存无显著差异(p=0.304),临床成功率保守组94.5% vs 栓塞组97.3%(p=0.496);糖尿病是复发的唯一独立预测因子(HR 2.615,95%CI 1.288-5.306,p=0.008)。
要点
- 匹配后保守组与早期BAE组咯血无复发生存无显著差异(p=0.304)。
- 糖尿病是非重症咯血复发的唯一独立预测因子(HR 2.615,95%CI 1.288-5.306,p=0.008)。
- BAE可作为保守治疗失败后的有效挽救治疗。
核心结论
- 在良性病因的非重症咯血中,保守管理与BAE显示可比的结果;糖尿病是复发的独立预测因子,BAE作为保守治疗失败后的挽救治疗有效。
研究设计与样本
- 回顾性倾向评分匹配比较研究,纳入320例非重症咯血患者(保守组210例,BAE组110例),排除潜在恶性肿瘤、大咯血或临床资料不完整者;倾向评分基于年龄、性别、合并症和影像学表现等基线变量估计;主要结局为咯血无复发生存(HFS),采用Cox比例风险回归分析临床和影像因素与HFS的关联。
关键影像表现/征象
- 倾向评分匹配前,BAE组结核后残留改变和空洞性病变的影像学表现更常见(分别为22.7% vs 13.3%,p=0.032;12.7% vs 5.7%,p=0.029)。
诊断标准与关键数值
- 倾向评分匹配后110对基线变量均衡。
- 临床成功率保守组94.5% vs BAE组97.3%(p=0.496)。
- 匹配队列中两组HFS无显著差异(p=0.304)。
- 糖尿病是复发的唯一独立预测因子(HR 2.615,95%CI 1.288-5.306,p=0.008);糖尿病患者HFS显著更短(p=0.003)。
临床应用与阅片要点
- 作者结论认为,在良性病因的非重症咯血中保守管理与BAE结果可比。
- 作者结论认为,糖尿病是复发的独立预测因子。
- 作者结论认为,BAE可作为保守治疗失败后的有效挽救治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to compare the effectiveness of hemoptysis control between patients managed conservatively and early bronchial artery embolization (BAE), and to identify clinical factors associated with recurrence.
METHODS: Patients with underlying malignancy, massive hemoptysis, or incomplete clinical data were excluded. 320 patients with non-severe hemoptysis were included (210 conservative, 110 BAE). Propensity scores were estimated using baseline variables including age, sex, comorbidities, and radiologic findings. Hemoptysis-free survival (HFS) was the primary outcome. Cox proportional hazards regression was used to assess associations between clinical and radiological factors and HFS.
RESULTS: Before PSM, radiological finding of post-tuberculous residual changes and cavitary lesion were more prevalent in the BAE group (22.7 % vs. 13.3 %, p = 0.032; 12.7 % vs. 5.7 %, p = 0.029, respectively).After PSM, 110 matched pairs showed balanced baseline variables. Clinical success rates were 94.5 % in the conservative group and 97.3 % in the BAE group (p = 0.496). In the PSM cohort, HFS did not differ significantly between groups (p = 0.304). Diabetes mellitus (DM) was the only independent predictor of recurrence (HR 2.615, 95 % CI 1.288-5.306, p = 0.008). Patients with DM had significantly shorter HFS (p = 0.003).
CONCLUSION: Conservative management and BAE showed comparable outcomes in non-severe hemoptysis of benign etiology. Diabetes mellitus was an independent predictor of recurrence, and BAE served effectively as rescue therapy after conservative treatment failure.
引用
- Kim KY, Yoon CJ, Lee JH, et al. Treatment of non-severe hemoptysis: A retrospective propensity score-matched comparison between conservative management and bronchial artery embolization. Eur J Radiol. 2025. PMID: 41389559. doi:10.1016/j.ejrad.2025.112604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。